牛叉诊股

[{"date":"2025.10.31","stock":"2.34","trade":"3.64","ind":"-1.14"},{"date":"2025.10.30","stock":"-0.36","trade":"-1.21","ind":"-1.16"},{"date":"2025.10.29","stock":"0.93","trade":"0.27","ind":"1.95"},{"date":"2025.10.28","stock":"-0.54","trade":"-0.37","ind":"-0.44"},{"date":"2025.10.27","stock":"1.68","trade":"0.79","ind":"1.51"},{"date":"2025.10.24","stock":"0.03","trade":"-0.38","ind":"2.02"},{"date":"2025.10.23","stock":"1.93","trade":"-1.12","ind":"0.22"},{"date":"2025.10.22","stock":"0.85","trade":"0.67","ind":"-0.62"},{"date":"2025.10.21","stock":"0.73","trade":"1.33","ind":"2.06"},{"date":"2025.10.20","stock":"-0.81","trade":"0.37","ind":"0.98"},{"date":"2025.10.17","stock":"0.13","trade":"-1.01","ind":"-3.04"},{"date":"2025.10.16","stock":"-0.73","trade":"0.19","ind":"-0.25"},{"date":"2025.10.15","stock":"1.08","trade":"2.81","ind":"1.73"},{"date":"2025.10.14","stock":"0.15","trade":"-1.22","ind":"-2.54"},{"date":"2025.10.13","stock":"-1.25","trade":"-0.84","ind":"-0.93"},{"date":"2025.10.10","stock":"2.74","trade":"-0.24","ind":"-2.70"},{"date":"2025.10.09","stock":"1.60","trade":"-0.39","ind":"1.47"},{"date":"2025.09.30","stock":"-0.41","trade":"0.72","ind":"0.35"},{"date":"2025.09.29","stock":"-0.38","trade":"-0.14","ind":"2.05"},{"date":"2025.09.26","stock":"-0.44","trade":"-1.67","ind":"-1.76"},{"date":"2025.09.25","stock":"-1.03","trade":"-0.91","ind":"0.67"}]

华特达因,深证成指,化学制药指数

压力支撑

该股压力位为33.65元，支撑位为33.05元。

[{"text":"\u538b\u529b\u4f4d","value":"33.65","date":1761840000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"33.05","date":1761840000,"color":"0x0b52a1"}]

多空趋势

多头行情中，目前处于回落整理阶段且下跌有加速趋势。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：6.1资金面打败了89%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

化学制药行业，近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。

更新时间：10月31日 20:30

机构今日流向(万元)	5587.31	机构5日流向(万元)	1400.31
机构10日流向(万元)	-4732.94	机构20日流向(万元)	-15121.09

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量增加422.80万股，其中基金净增仓3家，主力净增仓76家，有一定的中长期投资价值。

截止2025-06-30，共235家主力机构（基金230家，一般法人2家，社保基金2家，券商1家），持仓量总计9845.34万股，占流通A股42.04%
其中，基金持仓与2024-12-31相比：
增仓：14家，增持 121.59万股
减仓：11家，减持 117.57万股
新出现在主力名单中：192家，持有2696.95万股
从主力名单中消失：116家，原持有2609.8万股

消息面诊股

诊断结果：6.2消息面打败了88%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	高管变动	取消监事会	2025-08-26
一般消息	股东大会	临时股东大会	2025-08-08
利好	分红转增	10派5元(含税)	2025-08-08
一般消息	高管变动	因个人原因	2025-04-01
利好	分红转增	10派20元(含税)	2025-03-21

一年消息统计

	所有消息	重大消息	非重大消息
利好	2条	0条	2条
利空	0条	0条	0条

行业面诊股

诊断结果：5.8行业面打败了66%的股票化学制药行业最新资金流向

近10日来该行业走势不明显，接近大盘。最近120个交易日，机构对该行业关注较少，无任何评级。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，接近大盘。

[{"date":"2025.10.31","price":"-1.14","value":"3.64"},{"date":"2025.10.30","price":"-1.16","value":"-1.21"},{"date":"2025.10.29","price":"1.95","value":"0.27"},{"date":"2025.10.28","price":"-0.44","value":"-0.37"},{"date":"2025.10.27","price":"1.51","value":"0.79"},{"date":"2025.10.24","price":"2.02","value":"-0.38"},{"date":"2025.10.23","price":"0.22","value":"-1.12"},{"date":"2025.10.22","price":"-0.62","value":"0.67"},{"date":"2025.10.21","price":"2.06","value":"1.33"},{"date":"2025.10.20","price":"0.98","value":"0.37"},{"date":"2025.10.17","price":"-3.04","value":"-1.01"},{"date":"2025.10.16","price":"-0.25","value":"0.19"},{"date":"2025.10.15","price":"1.73","value":"2.81"},{"date":"2025.10.14","price":"-2.54","value":"-1.22"},{"date":"2025.10.13","price":"-0.93","value":"-0.84"},{"date":"2025.10.10","price":"-2.70","value":"-0.24"},{"date":"2025.10.09","price":"1.47","value":"-0.39"},{"date":"2025.09.30","price":"0.35","value":"0.72"},{"date":"2025.09.29","price":"2.05","value":"-0.14"},{"date":"2025.09.26","price":"-1.76","value":"-1.67"},{"date":"2025.09.25","price":"0.67","value":"-0.91"}]

深证成指,化学制药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	常山药业	46.37%	29.65%	6.1分
2	宏源药业	35.98%	17.27%	5.5分
3	亚太药业	32.17%	11.53%	6.2分
4	康芝药业	30.64%	21.22%	6.4分
5	多瑞医药	30.05%	2.02%	5.1分
6	*ST景峰	28.35%	3.28%	5.7分
7	兴齐眼药	19.79%	7.98%	6.5分
8	-	14.93%	10.41%	分
9	金石亚药	14.26%	-3.17%	6.0分
10	亨迪药业	13.30%	-1.45%	5.1分
11	联环药业	12.51%	13.27%	5.9分
12	广济药业	11.40%	-0.57%	6.0分
13	海南海药	11.07%	6.99%	6.2分
14	-	10.87%	15.56%	分
15	-	10.52%	6.63%	分
16	-	10.52%	5.92%	分
17	-	10.00%	8.52%	分
18	华特达因	9.55%	4.08%	5.9分
19	纳微科技	9.47%	3.44%	6.7分
20	华邦健康	9.15%	-0.81%	5.3分
21	哈三联	9.12%	-0.35%	5.0分
22	海正药业	8.52%	7.58%	6.9分
23	山河药辅	8.49%	2.20%	5.1分
24	舒泰神	7.89%	12.75%	5.8分
25	威尔药业	7.83%	5.43%	6.4分
26	赛分科技	7.81%	0.46%	6.2分
27	美诺华	7.68%	9.16%	6.1分
28	-	7.63%	5.42%	分
29	誉衡药业	7.59%	6.92%	6.5分
30	东亚药业	7.57%	2.35%	6.0分
31	仟源医药	7.20%	3.33%	6.2分
32	前沿生物	7.20%	13.69%	6.3分
33	润都股份	6.24%	4.10%	5.3分
34	双鹭药业	6.19%	0.53%	5.7分
35	华仁药业	5.92%	1.49%	5.8分
36	海辰药业	5.91%	15.24%	5.5分
37	民生健康	5.86%	0.84%	5.3分
38	汉商集团	5.65%	0.71%	6.1分
39	辰欣药业	5.47%	-8.70%	5.3分
40	ST天圣	5.33%	1.38%	5.1分
41	西点药业	5.05%	-1.09%	5.2分
42	罗欣药业	4.95%	-0.93%	5.2分
43	圣诺生物	4.86%	7.70%	6.9分
44	拓新药业	4.85%	2.55%	5.2分
45	福安药业	4.66%	1.58%	5.5分
46	德展健康	4.53%	5.04%	5.7分
47	金陵药业	4.53%	0.28%	5.7分
48	奥锐特	4.31%	3.61%	6.6分
49	-	4.27%	4.45%	分
50	川宁生物	4.11%	2.43%	5.7分
51	富士莱	4.08%	-0.34%	5.0分
52	共同药业	4.05%	-1.93%	5.1分
53	津药药业	3.93%	0.24%	5.9分
54	东北制药	3.74%	-1.94%	5.8分
55	溢多利	3.70%	1.45%	4.7分
56	东诚药业	3.59%	7.88%	6.5分
57	新和成	3.40%	4.61%	6.5分
58	海欣股份	3.35%	0.74%	5.6分
59	易明医药	3.23%	2.60%	5.7分
60	哈药股份	3.10%	-1.35%	5.6分
61	立方制药	3.01%	0.89%	6.1分
62	华润双鹤	2.94%	2.07%	6.4分
63	华北制药	2.92%	-1.32%	5.9分
64	富祥药业	2.86%	2.36%	4.9分
65	河化股份	2.78%	-2.76%	5.8分
66	*ST三圣	2.74%	-1.41%	3.9分
67	新天地	2.65%	-0.53%	5.1分
68	莎普爱思	2.56%	-0.99%	5.8分
69	*ST赛隆	2.51%	-4.13%	5.1分
70	海思科	2.44%	11.80%	6.5分
71	莱美药业	2.43%	1.31%	5.3分
72	鲁抗医药	2.35%	-0.99%	5.6分
73	赛托生物	2.34%	2.41%	5.2分
74	宣泰医药	2.33%	3.00%	5.9分
75	司太立	2.29%	3.43%	6.4分
76	昂利康	2.21%	1.51%	5.2分
77	尔康制药	1.98%	4.94%	6.1分
78	复旦张江	1.86%	2.87%	6.1分
79	苑东生物	1.83%	16.43%	7.1分
80	-	1.75%	0.31%	分
81	天宇股份	1.71%	3.23%	5.3分
82	丰原药业	1.68%	-0.60%	5.4分
83	通化金马	1.57%	2.90%	5.7分
84	海森药业	1.57%	-0.50%	5.1分
85	本立科技	1.47%	-3.38%	4.9分
86	浙江医药	1.46%	0.83%	5.9分
87	国邦医药	1.43%	2.06%	6.3分
88	神奇制药	1.41%	0.15%	5.9分
89	中关村	1.37%	-3.54%	5.5分
90	福元医药	1.36%	4.63%	6.4分
91	千红制药	1.31%	5.68%	6.1分
92	海普瑞	1.00%	2.10%	6.2分
93	天新药业	0.75%	-0.66%	5.3分
94	广生堂	0.33%	6.10%	5.6分
95	能特科技	0.26%	-1.28%	5.7分
96	灵康药业	0.00%	1.08%	6.0分
97	海翔药业	-0.17%	0.35%	5.3分
98	奥翔药业	-0.39%	1.08%	6.1分
99	永安药业	-0.63%	-0.23%	4.0分
100	人福医药	-0.70%	1.78%	5.9分
101	*ST苏吴	-1.00%	-6.60%	4.5分
102	新华制药	-1.31%	-1.49%	5.5分
103	-	-1.34%	5.04%	分
104	华东医药	-1.42%	5.03%	6.4分
105	百利天恒	-1.46%	5.88%	6.2分
106	吉贝尔	-1.54%	10.41%	6.3分
107	健康元	-1.62%	0.50%	5.7分
108	小方制药	-2.18%	0.68%	5.8分
109	北陆药业	-2.21%	3.02%	6.1分
110	同和药业	-2.23%	-5.23%	5.0分
111	花园生物	-2.34%	1.25%	5.3分
112	艾力斯	-2.36%	0.47%	6.5分
113	ST复华	-2.49%	8.70%	5.4分
114	国药现代	-2.53%	-3.79%	5.4分
115	键凯科技	-2.83%	3.62%	6.0分
116	向日葵	-3.00%	11.07%	4.7分
117	九典制药	-3.04%	-2.24%	5.1分
118	仙琚制药	-3.07%	-1.15%	5.5分
119	北大医药	-3.33%	-6.90%	5.4分
120	一品红	-3.34%	7.12%	5.8分
121	复星医药	-3.63%	0.41%	6.2分
122	力生制药	-3.99%	-1.40%	5.0分
123	信立泰	-4.32%	10.80%	6.6分
124	亚虹医药	-4.72%	5.00%	5.8分
125	卫信康	-4.86%	-6.22%	5.7分
126	丽珠集团	-4.97%	0.69%	5.7分
127	海创药业	-4.97%	3.22%	6.1分
128	健友股份	-5.01%	4.15%	5.7分
129	ST诺泰	-5.01%	-1.87%	5.9分
130	悦康药业	-5.08%	0.98%	5.7分
131	微芯生物	-5.16%	6.60%	6.2分
132	科源制药	-5.88%	0.79%	4.8分
133	普洛药业	-5.99%	1.30%	5.7分
134	百济神州	-5.99%	6.06%	6.2分
135	泽璟制药	-6.09%	2.04%	6.3分
136	亿帆医药	-6.40%	1.70%	5.4分
137	科伦药业	-6.57%	1.04%	5.9分
138	泰恩康	-6.63%	5.10%	4.2分
139	上海谊众	-7.39%	-1.51%	5.7分
140	华纳药厂	-7.99%	3.35%	6.4分
141	汇宇制药	-8.04%	4.30%	6.5分
142	翰宇药业	-8.91%	0.67%	5.6分
143	益方生物	-9.28%	12.77%	6.3分
144	诚意药业	-9.29%	-6.07%	5.3分
145	京新药业	-9.42%	3.52%	6.1分
146	金城医药	-10.03%	2.52%	5.6分
147	恒瑞医药	-11.24%	-2.06%	6.1分
148	迪哲医药	-11.39%	5.34%	6.1分
149	恩华药业	-12.26%	-1.25%	5.5分
150	首药控股	-12.60%	4.46%	6.0分
151	盟科药业	-12.66%	-0.66%	5.5分
152	华海药业	-12.78%	3.73%	6.0分
153	博瑞医药	-13.57%	7.51%	6.0分
154	奥赛康	-16.37%	4.34%	6.0分
155	贝达药业	-18.18%	-0.09%	5.5分
156	南新制药	-20.88%	8.91%	6.1分
157	新诺威	-30.27%	-2.29%	4.8分

<上一页 1 2 3 4 5...27 下一页>

行业评级

最近120个交易日，机构对该行业关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.5基本面打败了71%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：强（100分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 12/219 ， 12/219。

[{"date":"2025-09-30","value":"14.16","vol":"1.45"},{"date":"2025-06-30","value":"11.86","vol":"1.21"},{"date":"2025-03-31","value":"6.07","vol":"-0.17"},{"date":"2024-12-31","value":"17.50","vol":"19.51"},{"date":"2024-09-30","value":"12.72","vol":"4.61"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	14.16	11.86	6.07	17.50	12.72
行业(%)	1.45	1.21	-0.17	19.51	4.61

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"84.44","vol":"49.21"},{"date":"2025-06-30","value":"85.78","vol":"49.43"},{"date":"2025-03-31","value":"86.31","vol":"49.23"},{"date":"2024-12-31","value":"83.83","vol":"50.77"},{"date":"2024-09-30","value":"84.04","vol":"50.51"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	84.44	85.78	86.31	83.83	84.04
行业(%)	49.21	49.43	49.23	50.77	50.51

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 25/219 ， 53/219。

[{"date":"2025-09-30","value":"16.30","vol":"142.42"},{"date":"2025-06-30","value":"1.39","vol":"78.53"},{"date":"2025-03-31","value":"7.78","vol":"-0.84"},{"date":"2024-12-31","value":"-14.08","vol":"17.76"},{"date":"2024-09-30","value":"-19.83","vol":"45.69"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	16.30	1.39	7.78	-14.08	-19.83
行业(%)	142.42	78.53	-0.84	17.76	45.69

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"11.67","vol":"-6.13"},{"date":"2025-06-30","value":"1.69","vol":"56.29"},{"date":"2025-03-31","value":"8.13","vol":"-21.21"},{"date":"2024-12-31","value":"-11.90","vol":"-20.55"},{"date":"2024-09-30","value":"-20.70","vol":"-32.33"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	11.67	1.69	8.13	-11.90	-20.70
行业(%)	-6.13	56.29	-21.21	-20.55	-32.33

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 52/219 ， 21/219。

[{"date":"2025-09-30","value":"0.33","vol":"0.30"},{"date":"2025-06-30","value":"0.25","vol":"0.21"},{"date":"2025-03-31","value":"0.12","vol":"0.10"},{"date":"2024-12-31","value":"0.42","vol":"0.43"},{"date":"2024-09-30","value":"0.28","vol":"0.33"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.33	0.25	0.12	0.42	0.28
行业(次)	0.30	0.21	0.10	0.43	0.33

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"3.46","vol":"1.96"},{"date":"2025-06-30","value":"2.23","vol":"1.31"},{"date":"2025-03-31","value":"1.16","vol":"0.67"},{"date":"2024-12-31","value":"4.39","vol":"3.22"},{"date":"2024-09-30","value":"2.17","vol":"2.18"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	3.46	2.23	1.16	4.39	2.17
行业(次)	1.96	1.31	0.67	3.22	2.18

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"64.89","vol":"4.21"},{"date":"2025-06-30","value":"111.96","vol":"2.81"},{"date":"2025-03-31","value":"8.79","vol":"-28.76"},{"date":"2024-12-31","value":"48.84","vol":"-371.46"},{"date":"2024-09-30","value":"63.61","vol":"-9.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	64.89	111.96	8.79	48.84	63.61
行业	4.21	2.81	-28.76	-371.46	-9.87

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.02","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.57","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	1.02	-	0.57	-
行业	0.00	1.72	0.00	1.99	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 132/219 ， 135/219。

[{"date":"2025-09-30","value":"7.12","vol":"3.50"},{"date":"2025-06-30","value":"7.65","vol":"3.67"},{"date":"2025-03-31","value":"4.67","vol":"3.59"},{"date":"2024-12-31","value":"8.40","vol":"3.34"},{"date":"2024-09-30","value":"8.38","vol":"3.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	7.12	7.65	4.67	8.40	8.38
行业	3.50	3.67	3.59	3.34	3.66

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"6.79","vol":"2.74"},{"date":"2025-06-30","value":"7.27","vol":"2.89"},{"date":"2025-03-31","value":"4.48","vol":"2.81"},{"date":"2024-12-31","value":"8.13","vol":"2.64"},{"date":"2024-09-30","value":"7.88","vol":"2.92"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	6.79	7.27	4.48	8.13	7.88
行业	2.74	2.89	2.81	2.64	2.92

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 125/219 ， 117/219。

[{"date":"2025-09-30","value":"11.99","vol":"33.67"},{"date":"2025-06-30","value":"11.27","vol":"33.79"},{"date":"2025-03-31","value":"17.51","vol":"34.04"},{"date":"2024-12-31","value":"10.52","vol":"34.19"},{"date":"2024-09-30","value":"10.33","vol":"33.02"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	11.99	11.27	17.51	10.52	10.33
行业(%)	33.67	33.79	34.04	34.19	33.02

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.20","vol":"0.94"},{"date":"2025-06-30","value":"0.19","vol":"0.88"},{"date":"2025-03-31","value":"0.29","vol":"1.46"},{"date":"2024-12-31","value":"0.18","vol":"0.84"},{"date":"2024-09-30","value":"0.17","vol":"0.73"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.20	0.19	0.29	0.18	0.17
行业(%)	0.94	0.88	1.46	0.84	0.73

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。

研究机构	评级日期	最新评级	上次评级
兴业证券	2025-10-26	增持
华福证券	2025-08-15	买入
光大证券	2025-08-08	增持

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"3.80","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"5.27","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.85","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.16","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"5.57","blueLineValue":"2.38","type":"YC"}]

[华特达因]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]